Literature DB >> 31560080

[Fast growing, bleeding nodule on the heel].

Thomas Kuntz1, Antonia Viazis1, Bijan Koushk-Jalali1, Frank Oellig2, Ulrike Wieland3, Alexander Kreuter4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31560080     DOI： 10.1007/s00105-019-04487-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  7 in total

1.  Classical Kaposi sarcoma: prognostic factor analysis of 248 patients.

Authors:  Baruch Brenner; Alina Weissmann-Brenner; Erica Rakowsky; Sara Weltfriend; Eyal Fenig; Rachel Friedman-Birnbaum; Aaron Sulkes; Shai Linn
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

Review 2.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

Review 3.  Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment.

Authors:  Manisha Bhutani; Mark N Polizzotto; Thomas S Uldrick; Robert Yarchoan
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

Review 4.  Treatments for classic Kaposi sarcoma: a systematic review of the literature.

Authors:  Elodie Régnier-Rosencher; Bernard Guillot; Nicolas Dupin
Journal:  J Am Acad Dermatol       Date:  2012-06-12       Impact factor: 11.527

5.  A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.

Authors:  D Denis; V Seta; E Regnier-Rosencher; N Kramkimel; J Chanal; M-F Avril; N Dupin
Journal:  J Eur Acad Dermatol Venereol       Date:  2018-02-14       Impact factor: 6.166

Review 6.  Kaposi sarcoma: a continuing conundrum.

Authors:  Robert A Schwartz; Giuseppe Micali; Maria Rita Nasca; Laura Scuderi
Journal:  J Am Acad Dermatol       Date:  2008-08       Impact factor: 11.527

Review 7.  Kaposi sarcoma.

Authors:  Oana Radu; Liron Pantanowitz
Journal:  Arch Pathol Lab Med       Date:  2013-02       Impact factor: 5.534
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.